These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 63304)

  • 1. Pharmacological properties of N-(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'), a new anti-atopic agent.
    Azuma H; Banno K; Yoshimura T
    Br J Pharmacol; 1976 Dec; 58(4):483-8. PubMed ID: 63304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological properties of N-(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'), a new anti-atopic agent. (5).--Influence of N-5' on the histamine release from peritoneal exudate cells (author's transl)].
    Nakazawa M; Yoshimura T; Naito J; Azuma H
    Nihon Yakurigaku Zasshi; 1978 May; 74(4):483-90. PubMed ID: 81163
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
    Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological properties of N-(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'), a new anti-atopic agent. (4).--Anti-inflammatory activity of N-5' (author's transl)].
    Nakazawa M; Yoshimura T; Naito J; Azuma H
    Nihon Yakurigaku Zasshi; 1978 May; 74(4):473-81. PubMed ID: 700512
    [No Abstract]   [Full Text] [Related]  

  • 5. The inhibition mechanism of histamine release by N-(3,4-dimethoxycinnamoyl) anthranilic acid.
    Koda A; Kurashina Y; Nakazawa M
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):244-5. PubMed ID: 2409023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-allergic and anti-inflammatory properties of a potent histamine H1 receptor antagonist, desloratadine citrate disodium injection, and its anti-inflammatory mechanism on EA.hy926 endothelial cells.
    Jie Q; Kodithuwakku ND; Yuan X; He G; Chen M; Xu S; Wu Y
    Eur J Pharmacol; 2015 May; 754():1-10. PubMed ID: 25704613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-allergic properties of ethyl-3-methoxyphenyl-4-thiazolyl-2-oxamate (F 1865).
    Tarayre JP; Lauressergues H; Fauran F
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):165-76. PubMed ID: 6187305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological properties of N-(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'), a new anti-atopic agent. (3).--Influence on homologous passive cutaneous anaphylaxis mediated by homocytotropic antibody (author's transl)].
    Nakazawa M; Yoshimura T; Naito J; Azuma H
    Nihon Yakurigaku Zasshi; 1978 May; 74(4):467-72. PubMed ID: 700511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cinnarizine on IgE antibody mediated allergic reaction in mice and rats.
    Nagai H; Yakuo I; Yamada H; Inagaki N; Goto S; Koda A
    J Pharmacobiodyn; 1986 Nov; 9(11):923-7. PubMed ID: 2435883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory drug actions on allergic responses in guinea-pig skin.
    Paul W; Beets JL; Bray MA; Morley J
    Agents Actions; 1978 Oct; 8(5):509-14. PubMed ID: 31078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate inhibition by oral l-ephedrine of passive cutaneous anaphylaxis of rats: indirect inhibition of anaphylactic chemical mediator release from the mast cell.
    Shibata H; Minami E; Hirata R; Mizutani N; Nabe T; Kohno S
    Inflamm Res; 2000 Oct; 49(10):553-9. PubMed ID: 11089909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of TYB-2285 on passive cutaneous anaphylaxis in rats.
    Watanabe A; Tominaga T; Shutoh H; Hayashi H; Tsuji J; Koda A; Nagai H; Kumazawa Y; Shimada H
    Gen Pharmacol; 1997 Feb; 28(2):311-5. PubMed ID: 9013210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-allergic effects of ketanserin on animal models of allergic reactions.
    Nagai H; Suda H; Kitagaki K; Goto S; Miura T; Koda A
    Arch Int Pharmacodyn Ther; 1990; 307():172-82. PubMed ID: 1710442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-allergic action of glucocorticoids in rats.
    Nagai H; Takizawa T; Nakatomi I; Matsuura N; Koda A
    Jpn J Pharmacol; 1983 Apr; 33(2):349-55. PubMed ID: 6193304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of glucocorticoids on increased vascular permeability caused by passive cutaneous anaphylaxis and some chemical mediators in rats.
    Inagaki N; Miura T; Nagai H; Koda A
    Jpn J Pharmacol; 1988 Feb; 46(2):189-92. PubMed ID: 3379829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on vascular permeability increasing factors involved in 48-hour homologous PCA in the mouse ear.
    Inagaki N; Goto S; Yamasaki M; Nagai H; Koda A
    Int Arch Allergy Appl Immunol; 1986; 80(3):285-90. PubMed ID: 3087885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms for glucocorticoid inhibition of immediate hypersensitivity reactions in rats.
    Miura T; Inagaki N; Yoshida K; Nakajima T; Nagai H; Koda A
    Jpn J Pharmacol; 1992 May; 59(1):77-87. PubMed ID: 1380583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopharmacological studies of sodium copper chlorphyllin (SCC).
    Nagai H; Nishiyori T; Daikoku M; Koda A
    Jpn J Pharmacol; 1983 Aug; 33(4):819-28. PubMed ID: 6195383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological studies on rat passive cutaneous anaphylaxis (PCA) (author's transl)].
    Azuma Y
    Nihon Yakurigaku Zasshi; 1980 Nov; 76(8):685-96. PubMed ID: 6168549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.